Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-07-08 00:41 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | Polaris Management Co. VII, L.L.C. | 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 48,320 | +100.0% |
| 2016-07-08 03:04 | 2016-07-05 | RSE | N/A | Brookfield Retail Holdings IV-A Sub II LLC | Other | Other | BUY | $18.25 | 19,387,625 | $353,824,156 | 19,387,625 | +100.0% |
| 2016-07-07 13:03 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | Redmile Group, LLC | 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 432,746 | $5,409,325 | 49,793 | +100.0% |
| 2016-07-07 13:04 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | Flagship Ventures Fund IV, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 918,664 | +77.1% |
| 2016-07-07 13:02 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | Arch Venture Fund VII LP | 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 4,637,137 | +9.4% |
| 2016-07-08 03:05 | 2016-07-05 | RSE | N/A | BROOKFIELD ASSET MANAGEMENT INC. | 10% owner | Other | BUY | $18.25 | 57,887,442 | $1,056,445,817 | 1,000 | +100.0% |
| 2016-07-06 23:13 | 2016-07-01 | GMRE | Chiron Real Estate Inc. | ZH USA, LLC | 10% owner | Real Estate Investment Trusts | BUY | $12.75 | 1,179,019 | $15,030,134 | 2,604,500 | +82.7% |
| 2016-07-06 23:08 | 2016-07-01 | GMRE | Chiron Real Estate Inc. | Zhang Jing Guo | Director, 10% owner | Real Estate Investment Trusts | BUY | $12.75 | 1,179,019 | $15,030,134 | 2,604,500 | +82.7% |
| 2016-07-07 04:22 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | NELSEN ROBERT | Director, 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 4,637,137 | +9.4% |
| 2016-07-07 00:10 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | AISLING CAPITAL III LP | 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 908,565 | +78.7% |
| 2016-07-06 18:54 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | Flynn James E | 10% owner, Other | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 628,566 | +175.0% |
| 2016-07-05 23:05 | 2016-06-30 | TAT | N/A | Nokomis Capital, L.L.C. | 10% owner | Other | BUY | $0.66 | 1,595,470 | $1,052,851 | 4,437,760 | +56.1% |
| 2016-07-05 15:57 | 2016-06-30 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% owner | Pharmaceutical Preparations | BUY | $0.52 | 2,261,419 | $1,166,666 | 14,481,089 | +18.5% |
| 2016-07-01 23:06 | 2016-06-30 | OGEN-BC | ORAGENICS INC | KOSKI FAMILY LP | 10% owner | Pharmaceutical Preparations | BUY | $0.52 | 5,815,080 | $3,000,000 | 12,864,822 | +82.5% |
| 2016-07-01 23:40 | 2016-06-30 | FNTC | N/A | COHEN BETSY Z | Director | Other | BUY | $10.00 | 500,000 | $5,000,000 | 857,881 | +139.7% |
| 2016-07-02 00:01 | 2016-06-29 | N/A | Blue Owl Capital Corp | MSD CAPITAL L P | 10% owner | Other | BUY | $14.30 | 538,891 | $7,706,141 | 3,038,718 | +21.6% |
| 2016-07-01 18:04 | 2016-06-29 | AXDX | N/A | SCHULER JACK W | Director, 10% owner | Other | BUY | $13.95 | 90,147 | $1,257,145 | 12,192,305 | +0.7% |
| 2016-06-30 23:30 | 2016-06-29 | MLSS | MILESTONE SCIENTIFIC INC. | BP4 S.r.l. | Director, Officer, 10% owner - See Remarks | Orthopedic, Prosthetic & Surgical Appliances & Supplies | BUY | $2.00 | 1,000,000 | $2,000,000 | 3,000,000 | +50.0% |
| 2016-06-30 23:30 | 2016-06-29 | MLSS | MILESTONE SCIENTIFIC INC. | Trombetta Giandomenico | Director, Officer, 10% owner - See Remarks | Orthopedic, Prosthetic & Surgical Appliances & Supplies | BUY | $2.00 | 1,000,000 | $2,000,000 | 3,000,000 | +50.0% |
| 2016-06-30 23:35 | 2016-06-29 | N/A | Blue Owl Capital Corp | Ostrover Douglas I | Director, 10% owner | Other | BUY | $14.30 | 538,891 | $7,706,141 | 759,680 | +244.1% |
| 2016-07-01 02:27 | 2016-06-28 | RETA | N/A | McGaughy R Kent Jr | Director, 10% owner | Other | BUY | $19.78 | 164,600 | $3,255,936 | 632,780 | +35.2% |
| 2016-07-01 02:22 | 2016-06-28 | RETA | N/A | Traweek James W JR | 10% owner | Other | BUY | $19.78 | 164,600 | $3,255,936 | 632,780 | +35.2% |
| 2016-07-01 02:13 | 2016-06-28 | RETA | N/A | CPMG Inc | Director, 10% owner | Other | BUY | $19.78 | 164,600 | $3,255,936 | 88,920 | +100.0% |
| 2016-06-30 23:40 | 2016-06-29 | N/A | Blue Owl Capital Corp | SOROS FUND MANAGEMENT LLC | 10% owner | Other | BUY | $14.30 | 1,010,421 | $14,449,020 | 5,697,598 | +21.6% |
| 2016-06-30 23:10 | 2016-06-28 | NSH | N/A | GREEHEY WILLIAM E | Director, 10% owner | Other | BUY | $25.15 | 40,000 | $1,005,952 | 385,889 | +11.6% |
| 2016-06-30 04:58 | 2016-06-24 | CASI | N/A | SPARKLE BYTE LTD | 10% owner | Other | BUY | $1.19 | 3,753,855 | $4,467,087 | 8,498,765 | +79.1% |
| 2016-06-30 01:50 | 2016-06-29 | N/A | Blue Owl Capital Corp | Brown University | 10% owner | Other | BUY | $14.30 | 538,891 | $7,706,141 | 3,038,718 | +21.6% |
| 2016-06-29 23:47 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | Osage University Partners II, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 350,000 | $4,900,000 | 862,543 | +68.3% |
| 2016-06-29 23:46 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | Nanodimension Management Ltd | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 385,000 | $5,390,000 | 1,045,957 | +58.2% |
| 2016-06-29 23:45 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | Nashat Amir | Director, 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 150,000 | $2,100,000 | 1,836,703 | +8.9% |
| 2016-06-30 01:14 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | RUSNANO | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 107,143 | $1,500,002 | 157,009 | +214.9% |
| 2016-06-29 23:44 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | Polaris Venture Management Co. V, L.L.C. | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 150,000 | $2,100,000 | 1,836,703 | +8.9% |
| 2016-06-29 23:49 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | GORDON CARL L | Director, 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 550,000 | $7,700,000 | 1,825,415 | +43.1% |
| 2016-06-30 00:27 | 2016-06-27 | PRTK | N/A | Lim Richard J. | Director | Other | BUY | $13.00 | 461,538 | $5,999,994 | 1,187,365 | +63.6% |
| 2016-06-30 00:26 | 2016-06-27 | PRTK | N/A | Omega Fund III, L.P. | 10% owner | Other | BUY | $13.00 | 461,538 | $5,999,994 | 779,802 | +145.0% |
| 2016-06-30 01:35 | 2016-06-27 | PDVW | Anterix Inc. | Owl Creek Asset Management, L.P. | 10% owner | Telephone Communications (No Radiotelephone) | BUY | $19.97 | 77,311 | $1,543,939 | 2,066,728 | +3.9% |
| 2016-06-30 03:55 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 550,000 | $7,700,000 | 1,825,415 | +43.1% |
| 2016-06-29 23:45 | 2016-06-27 | SELB | Cartesian Therapeutics, Inc. | TAS Partners, LLC | Director | Pharmaceutical Preparations | BUY | $14.00 | 710,000 | $9,940,000 | 1,237,028 | +134.7% |
| 2016-06-29 02:01 | 2016-06-24 | MFRM | N/A | 40 North Latitude Fund LP | 10% owner | Other | BUY | $32.40 | 48,700 | $1,577,953 | 1,486,417 | +3.4% |
| 2016-06-28 21:41 | 2016-06-24 | RETA | N/A | McGaughy R Kent Jr | Director, 10% owner | Other | BUY | $19.26 | 73,403 | $1,413,566 | 468,180 | +18.6% |
| 2016-06-28 21:39 | 2016-06-24 | RETA | N/A | Traweek James W JR | 10% owner | Other | BUY | $19.26 | 73,403 | $1,413,566 | 468,180 | +18.6% |
| 2016-06-28 21:38 | 2016-06-24 | RETA | N/A | CPMG Inc | Director, 10% owner | Other | BUY | $19.26 | 73,403 | $1,413,566 | 259,476 | +39.4% |
| 2016-06-29 03:51 | 2016-06-24 | LE | LANDS' END, INC. | LAMPERT EDWARD S | 10% owner | Retail-Family Clothing Stores | BUY | $15.73 | 124,830 | $1,963,176 | 11,741,346 | +1.1% |
| 2016-06-28 23:36 | 2016-06-24 | WWWW | N/A | Okumus Fund Management Ltd. | 10% owner | Other | BUY | $17.02 | 962,277 | $16,373,624 | 9,560,033 | +11.2% |
| 2016-06-25 00:07 | 2016-06-22 | PDVW | Anterix Inc. | Owl Creek Asset Management, L.P. | 10% owner | Telephone Communications (No Radiotelephone) | BUY | $21.66 | 58,500 | $1,266,894 | 1,989,417 | +3.0% |
| 2016-06-24 00:16 | 2016-06-21 | BTX | Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS LP | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $2.39 | 2,732,636 | $6,531,000 | 24,897,032 | +12.3% |
| 2016-06-22 22:12 | 2016-06-21 | ALXA | N/A | Grupo Ferrer Internacional, S.A. | 10% owner | Other | BUY | $0.90 | 19,465,714 | $17,519,143 | 21,832,649 | +822.4% |
| 2016-06-23 04:20 | 2016-06-20 | OSGIQ | N/A | CYRUS CAPITAL PARTNERS, L.P. | Director, 10% owner, Other | Other | BUY | $11.53 | 323,705 | $3,733,225 | 9,380,189 | +3.6% |
| 2016-06-22 21:51 | 2016-06-22 | BIOS | Option Care Health, Inc. | Coliseum Capital Management, LLC | Director, 10% owner | Services-Home Health Care Services | BUY | $2.00 | 4,200,000 | $8,400,000 | 5,622,410 | +295.3% |
| 2016-06-22 04:25 | 2016-06-17 | LC | LendingClub Corp | Chen Tian Qiao | 10% owner | Personal Credit Institutions | BUY | $4.01 | 24,299,900 | $97,398,859 | 57,739,270 | +72.7% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.